Academic Respiratory Physician @Charlies_Resp & @Resp_Health | Senior Lecturer @uwanews | #NewPI #COPD #Asthma š¦šŗ š²š¾
Perth, Western Australia
Joined December 2010
- Tweets1.7K
- Following1.5K
- Followers1K
- Likes1.3K
Sanjay Ramakrishnan retweeted
ABRA kadabra šŖ.. possibly a new drug for COPD š¤š¾
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Read open access here: thelancet.com/journals/lanreā¦
@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine
Sanjay Ramakrishnan retweeted
Hereās the study thatās been making the headlines.
Congratulations to all the team for delivering this challenging study.
Exciting times aheadā¦ š ā¬ļø
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Read open access here: thelancet.com/journals/lanreā¦
@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine
Sanjay Ramakrishnan retweeted
šFor the first time in 50 years there is a new treatment that helps improve the management of asthma and chronic obstructive pulmonary disease attacks! @UWAresearch @Resp_Health @SanjayResp
uwa.au/awq4bm
Sanjay Ramakrishnan retweeted
Breaking News! š A major breakthrough in asthma treatment! š« A trial managed by @OxfordRespTrial has discovered the first new treatment for asthma attacks in 50 years. This could revolutionize care for millions. @UniofOxford @NDMOxford #research bbc.co.uk/news/articles/cev9ā¦
Sanjay Ramakrishnan retweeted
Biologics for exacerbations, game-changer!
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Read open access here: thelancet.com/journals/lanreā¦
@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine
Sanjay Ramakrishnan retweeted
Such an important study. In people with acute asthma and COPD with eosinophilia regimes containing benralizumab were superior to prednisone alone in reference treatment failure at 90 days
Sanjay Ramakrishnan retweeted
Asthma & COPD breakthrough! For 1st time in 50 yrs, a new treatment's been found. Dr Sanjay Ramakrishnan's (@SanjayResp) trial shows benralizumab injection reduces severe asthma & COPD attacks. resphealth.org.au/2024/11/neā¦
#AsthmaTreatment #COPD #RespiratoryHealth
Woohooo! Thank you for showcasing our work @LancetRespirMed
Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
Read open access here: thelancet.com/journals/lanreā¦
@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine
Wow. ABRA was highlighted by @EricTopol Thank you!
So proud to see this out for everyone to read. Our patients with and asthma and COPD deserve the best.
@LancetRespirMed @MonaBafadhel
Some very good news for people with asthma and COPD.
The first new treatment for acute attacks in over 50 yearsāa monoclonal antibody vs interleukin-5 receptor-Ī±āwith efficacy in a randomized trial
thelancet.com/journals/lanreā¦ @LancetRespirMed @SanjayResp @MonaBafadhel @kingsmedicine
@BBCWorld highlighting the patient impact of the ABRA trial. Thank you to Alison and Geoff for their amazing support of this study
bbc.com/news/articles/cev937ā¦
Sanjay Ramakrishnan retweeted
Today is #worldCODPday, started by @gold_copd. This years theme is "Know Your Lung Function" as #spirometry is important for diagnosis & monitoring lung health.
TSANZ members worked with @ACSQHC to develop the recent clinical standards on COPD.
shorturl.at/zAWod
Sanjay Ramakrishnan retweeted
Our @Charlies_Resp experts stealing the show at the Airways 2024 meeting in Sydney (1/4)
Sanjay Ramakrishnan retweeted
And you can work with a world class pleural service! Spread the word for our new CF/Bronchiectasis consultant position please.
Are you a bronchiectasis nerd? Want to come live in a city with the best beaches in the world? Look no further. This is your dream job opportunity! @NMHS_WA
The @Resp_Health infrastructure will allow you to grow your research too! @tsanz_thoracic @BTSrespiratory @EuroRespSoc
Are you a bronchiectasis nerd? Want to come live in a city with the best beaches in the world? Look no further. This is your dream job opportunity! @NMHS_WA
The @Resp_Health infrastructure will allow you to grow your research too! @tsanz_thoracic @BTSrespiratory @EuroRespSoc
šØJOB OPPORTUNITY
@Charlies_Resp is looking for a new colleague with a sub specialist interest in CF and non-CF bronchiectasis. Come lead the state CF service. You will get to work at our collaborative unit with our amazing multi-professional team.
Ad š
search.jobs.wa.gov.au/page.pā¦
šØšØBig news for people with severe #asthma in Australia today. The Pharmaceutical Benefits Scheme (PBS) has changed the eligibility criteria for asthma biologics today (October 1). (1/3)
No more minimum cumulative oral corticosteroids dose. It was always so silly when patients had to take more oral steroids to get a medicine designed to reduce oral steroids harm.
This retrograde requirement is gone! (2/3)
Huge win for patients due to the advocacy from @AsthmaAustralia @tsanz_thoracic @GSK @AstraZeneca @sanofi
The right treatment for the right patient now without unnecessary additional harm š (3/3)